Insulin Workshops by BIDE Initiation of Insulin should not be delayed-Prof. Basit.
- Published in:
- 2012
- Publication type:
- Proceeding
Works matching DE "AVENTIS Pharma Ltd."
Results: 9
1
2
Aventis's main stakeholder all set to strike deal over Sanofi merger.
- Published in:
- Chemistry & Industry, 2004, n. 5, p. 4
- By:
- Publication type:
- Article
3
BIOEQUIVALENCE OF TWO FEXOFENADINE FORMULATIONS IN HEALTHY HUMAN VOLUNTEERS AFTER SINGLE ORAL ADMINISTRATION.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2007, v. 151, n. 1, p. 65, doi. 10.5507/bp.2007.011
- By:
- Publication type:
- Article
4
Antiinfective biotechs face partnering gap.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 2, p. 155, doi. 10.1038/nbt0205-155
- By:
- Publication type:
- Article
5
Millennium and Aventis in unique pact.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 8, p. 817, doi. 10.1038/78410
- By:
- Publication type:
- Article
6
Ruling favors Amgen.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 6, p. 581, doi. 10.1038/76331
- By:
- Publication type:
- Article
7
Insulin Inhalation – Pfizer/Nektar Therapeutics: HMR 4006, Inhaled PEG-Insulin – Nektar, PEGylated Insulin – Nektar.
- Published in:
- Drugs in R&D, 2004, v. 5, n. 3, p. 166
- By:
- Publication type:
- Article
8
Mdl 28170.
- Published in:
- Drugs in R&D, 2002, v. 3, n. 2, p. 109, doi. 10.2165/00126839-200203020-00007
- Publication type:
- Article
9
Triamcinolone Acetonide Hydrofluoroalkane Inhalation - Aventis: Azmacort HFA[sup ®] , Azmacort HFA-134a, RG 5016, Triamcinolone Acetonide HFA inhalation - Aventis.
- Published in:
- Drugs in R&D, 2002, v. 3, n. 2, p. 141, doi. 10.2165/00126839-200203020-00018
- Publication type:
- Article